Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-09-02 Sale |
2020-09-04 4:17 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
100 | $85 | $8,500 | 81,159 (Direct) |
View |
| 2020-09-02 Purchase |
2020-09-03 4:37 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
4,200 | $85.01 | $357,054 | 102,565 (Direct) |
View |
| 2020-08-25 Sale |
2020-08-27 4:13 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
7,112 | $80.13 | $569,892 | 72,045 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:13 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
3,717 | $76.63 | $284,828 | 101,018 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:11 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
660 | $76.06 | $50,200 | 29,356 (Direct) |
View |
| 2020-07-31 Sale |
2020-08-03 5:53 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
341 | $76.39 | $26,048 | 30,016 (Direct) |
View |
| 2020-07-31 Sale |
2020-08-03 5:51 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
896 | $76.39 | $68,444 | 649,062 (Direct) |
View |
| 2020-07-30 Sale |
2020-08-03 5:45 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
7,112 | $75 | $533,400 | 79,157 (Direct) |
View |
| 2020-07-21 Sale |
2020-07-23 7:43 pm |
NovoCure Ltd | NVCR | Ambrogi Michael J. Chief Operating Officer |
46,293 | $66.88 | $3,096,038 | 395,237 (Direct) |
View |
| 2020-07-21 Sale |
2020-07-23 7:32 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
10,000 | $66.93 | $669,334 | 99,973 (Direct) |
View |
| 2020-05-12 Sale |
2020-05-14 4:14 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
2,595 | $64.78 | $168,104 | 12,616 (Direct) |
View |
| 2020-05-11 Sale |
2020-05-12 4:22 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,611 | $63.73 | $102,666 | 23,621 (Direct) |
View |
| 2020-05-11 Sale |
2020-05-12 4:13 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
31,332 | $63.73 | $1,996,726 | 649,958 (Direct) |
View |
| 2020-05-07 Sale |
2020-05-11 4:17 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
62,896 | $64.11 | $4,032,390 | 740,057 (Direct) |
View |
| 2020-05-05 Sale |
2020-05-07 4:48 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
1,149 | $62.2 | $71,468 | 100,693 (Direct) |
View |
| 2020-05-05 Sale |
2020-05-07 4:41 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
60,164 | $63.36 | $3,812,170 | 920,489 (Direct) |
View |
| 2020-05-04 Sale |
2020-05-05 4:32 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
1,184 | $60.08 | $71,134 | 104,175 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-09-01 Option Award |
2020-09-04 4:38 pm |
N/A 2030-08-31 |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
17,240 | $0 | 37,778 (Direct) |
View |
| 2020-09-02 Exercise |
2020-09-04 4:17 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
100 | $7.03 | 81,159 (Direct) |
View |
| 2020-09-02 Exercise |
2020-09-04 4:17 pm |
N/A 2023-02-19 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
100 | $0 | 81,159 (Direct) |
View |
| 2020-09-01 Option Award |
2020-09-03 4:43 pm |
N/A 2030-08-31 |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
5,747 | $0 | 31,376 (Direct) |
View |
| 2020-09-01 Option Award |
2020-09-03 4:37 pm |
N/A 2030-08-31 |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
5,747 | $0 | 102,565 (Direct) |
View |
| 2020-09-01 Option Award |
2020-09-03 4:33 pm |
N/A 2030-08-31 |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer |
5,747 | $0 | 146,386 (Direct) |
View |
| 2020-08-25 Exercise |
2020-08-27 4:13 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
7,112 | $7.03 | 72,045 (Direct) |
View |
| 2020-08-25 Exercise |
2020-08-27 4:13 pm |
N/A 2023-02-19 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
7,112 | $0 | 72,045 (Direct) |
View |
| 2020-08-04 Option Award |
2020-08-05 4:36 pm |
N/A N/A |
NovoCure Ltd | NVCR | Madden Martin J. Director |
307 | $0 | 15,113 (Indirect) |
View |
| 2020-07-07 Option Award |
2020-08-03 5:53 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
325 | $50.41 | 30,016 (Direct) |
View |
| 2020-07-30 Exercise |
2020-08-03 5:45 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
7,112 | $7.03 | 79,157 (Direct) |
View |
| 2020-07-30 Exercise |
2020-08-03 5:45 pm |
N/A 2023-02-19 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
7,112 | $0 | 79,157 (Direct) |
View |
| 2020-07-31 Exercise |
2020-08-03 5:39 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
3,717 | $76.17 | 108,452 (Direct) |
View |
| 2020-07-31 Exercise |
2020-08-03 5:39 pm |
2020-07-31 N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
3,717 | $0 | 108,452 (Direct) |
View |
| 2020-07-21 Exercise |
2020-07-23 7:43 pm |
N/A N/A |
NovoCure Ltd | NVCR | Ambrogi Michael J. Chief Operating Officer |
33,793 | $21.15 | 395,237 (Direct) |
View |
| 2020-07-21 Exercise |
2020-07-23 7:43 pm |
N/A 2026-02-24 |
NovoCure Ltd | NVCR | Ambrogi Michael J. Chief Operating Officer |
46,293 | $0 | 395,237 (Direct) |
View |
| 2020-07-21 Exercise |
2020-07-23 7:43 pm |
N/A N/A |
NovoCure Ltd | NVCR | Ambrogi Michael J. Chief Operating Officer |
12,500 | $11.46 | 395,237 (Direct) |
View |
| 2020-07-21 Exercise |
2020-07-23 7:32 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
10,000 | $7.03 | 99,973 (Direct) |
View |
| 2020-07-21 Exercise |
2020-07-23 7:32 pm |
N/A 2023-02-19 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
10,000 | $0 | 99,973 (Direct) |
View |
| 2020-07-07 Option Award |
2020-07-08 4:25 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
325 | $50.41 | 101,018 (Direct) |
View |
| 2020-07-07 Option Award |
2020-07-08 4:24 pm |
N/A N/A |
NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel |
325 | $50.41 | 87,078 (Direct) |
View |
| 2020-07-07 Option Award |
2020-07-08 4:22 pm |
N/A N/A |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Financial Officer |
253 | $50.41 | 140,639 (Direct) |
View |
| 2020-07-07 Option Award |
2020-07-08 4:20 pm |
N/A N/A |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
325 | $50.41 | 30,357 (Direct) |
View |
| 2020-07-07 Option Award |
2020-07-08 4:18 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
284 | $50.41 | 197,632 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-12 6:14 pm |
N/A 2030-06-10 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
7,642 | $0 | 77,146 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-12 6:12 pm |
N/A 2030-06-10 |
NovoCure Ltd | NVCR | HILLEMAN JERYL L Director |
7,642 | $0 | 11,001 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-12 6:11 pm |
N/A 2030-06-10 |
NovoCure Ltd | NVCR | VERNON W ANTHONY Director |
7,642 | $0 | 166,231 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-12 6:09 pm |
N/A 2030-06-10 |
NovoCure Ltd | NVCR | Madden Martin J. Director |
7,642 | $0 | 19,907 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-12 6:07 pm |
N/A 2030-06-10 |
NovoCure Ltd | NVCR | Hung David Director |
7,642 | $0 | 11,001 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-12 6:03 pm |
N/A 2030-06-10 |
NovoCure Ltd | NVCR | McCoy Sherilyn S Director |
7,642 | $0 | 11,001 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-12 4:22 pm |
2020-05-08 N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
4,206 | $0 | 23,621 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-12 4:22 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
4,206 | $63.84 | 23,621 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-11 4:22 pm |
2020-05-08 N/A |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
1,402 | $0 | 28,432 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-11 4:22 pm |
N/A N/A |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
1,402 | $63.84 | 28,432 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-11 4:17 pm |
N/A N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
58,768 | $64.77 | 740,057 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-11 4:17 pm |
2020-05-07 N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
117,535 | $0 | 740,057 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-11 4:17 pm |
N/A N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
58,767 | $63.84 | 740,057 (Direct) |
View |
Ownership |
2020-05-07 9:20 pm |
N/A N/A |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
0 | $0 | 89,246 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-07 4:41 pm |
N/A N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
58,768 | $61.4 | 920,489 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 4:41 pm |
N/A N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
58,768 | $64.15 | 920,489 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-07 4:41 pm |
2020-05-06 N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
117,536 | $0 | 920,489 (Direct) |
View |
| 2020-05-04 Exercise |
2020-05-06 5:52 pm |
N/A N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
58,768 | $60.48 | 804,350 (Direct) |
View |
| 2020-05-04 Exercise |
2020-05-06 5:52 pm |
2020-05-04 N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
58,768 | $0 | 804,350 (Direct) |
View |
| 2020-05-01 Exercise |
2020-05-05 4:32 pm |
2019-05-01 N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
2,333 | $0 | 104,175 (Direct) |
View |
| 2020-05-01 Exercise |
2020-05-05 4:32 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
2,333 | $65.8 | 104,175 (Direct) |
View |